Agile Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AGRX and other ETFs, options, and stocks.

About AGRX

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive.

CEO

Alfred F. Altomari

CEOAlfred F. Altomari

Employees

Employees30

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1997

Founded1997

Employees

Employees30

AGRX Key Statistics

Market cap

8.02M

Market cap8.02M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

651.72K

Average volume651.72K

High today

—

High today—

Low today

—

Low today—

Open price

$0.19

Open price$0.19

Volume

0.00

Volume0.00

52 Week high

$29.60

52 Week high$29.60

52 Week low

$0.183

52 Week low$0.183

AGRX Earnings

-$8.40

-$5.60

-$2.80

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 29, After Hours

ActualExpected Mar 29, After Hours

Agile Therapeutics

Why Robinhood?

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. Show more

AGRX Key Statistics

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive.